Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

B-13 Tol1 Gene Transfer System


Technology Benefits

ΓùÅ Tol1 is a DNA-based transposable element. Simplicity and safety of usage in comparison with RNA-mediated elements and retroviruses. ΓùÅ High Capacity; maximum cargo capacity is >20kb.ΓùÅ Universal use: available for fish, frog and mammalian cells, such as mouse, human and possibly also for other mammals.


Technology Application

Biological Tool for gene engineering and gene therapy.


Detailed Technology Description

The Tol1 gene transfer system consists of two plasmids. One is Tol1 donor (pDon) and the other is transposase plasmid (pHel). For the generation of founder transgenic fish, pDon and pHel are co-injected into fish or frog embryos or mammalian cells.


Supplementary Information

Patent Number: WO2008072540A1
Application Number: WO2007JP73565A
Inventor: KOGA, Akihiko | HAMAGUCHI, Satoshi
Priority Date: 13 Dec 2006
Priority Number: WO2008072540A1
Application Date: 6 Dec 2007
Publication Date: 19 Jun 2008
IPC Current: C12N001509 | C12N000510 | C12N000910
Assignee Applicant: National University Corporation Nagoya University
Title: Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME | TRANSPOSASE DE FACTEUR TOL1 ET SYSTÈME D'INTRODUCTION D'ADN UTILISANT CELLE-CI
Usefulness: Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME | TRANSPOSASE DE FACTEUR TOL1 ET SYSTÈME D'INTRODUCTION D'ADN UTILISANT CELLE-CI
Summary: The Tol1 factor transposase is useful for introducing DNA of Tol1 factor which is useful in gene therapy.
Novelty: Novel transposable element of Oryzias latipes 1 Tol1 factor transposase having enzyme activity for transferring Tol1 factor, for introducing DNA of Tol1 factor useful in gene therapy


Industry

Biomedical


Sub Group

Medical Device


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View